Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Tumor marker in ovarian cancer].

Kan Komai1, Takashi Nishida

  • 1Dept. of Gynecology and Obstetrics, Kurume University School of Medicine, 67 Asahi-machi, Krume 830-0011, Japan.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|March 28, 2002
PubMed
Summary

The antigen CA125 is a useful tumor marker for ovarian cancer management, but its effectiveness is limited for early screening and monitoring due to other conditions and lack of effective treatments. New markers like lysophosphatidic acid and inhibin show promise.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of Menopausal Hormone Therapy on Strabismus, Strabismus Surgery, and Reoperation Rates.

American journal of ophthalmology·2026
Same author

Positive Airway Pressure and Long-Term Glaucoma Risk in Obstructive Sleep Apnea: A Cohort Study.

Ophthalmology. Glaucoma·2026
Same author

Glucagon Like Peptide 1 Receptor Agonists and Age-Related Macular Degeneration Incidence.

Ophthalmology. Retina·2026
Same author

Progression in Preperimetric Glaucoma Eyes With and Without Microvasculature Dropout.

American journal of ophthalmology·2026
Same author

Association of Deep Optic Nerve Head Structural Remodeling with Choroidal Microvasculature Dropout in Glaucoma with and without Myopia.

American journal of ophthalmology·2026
Same author

Risk Factors for Pneumonitis in Patients with Unresectable Advanced Non-small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors.

Internal medicine (Tokyo, Japan)·2026

Area of Science:

  • Oncology
  • Biochemistry
  • Gynecologic Oncology

Context:

  • Ovarian cancer management relies on accurate diagnostic and monitoring tools.
  • Tumor markers play a crucial role in assessing disease progression and treatment response.
  • Current limitations exist in the sensitivity and specificity of existing markers.

Purpose:

  • To review the current role of tumor markers in ovarian cancer management.
  • To evaluate the utility of CA125 and explore emerging markers.
  • To discuss the diagnostic and monitoring capabilities of tumor markers in epithelial ovarian cancer.

Summary:

  • The antigen CA125 remains the primary tumor marker for epithelial ovarian cancer.
  • CA125 levels can be affected by non-cancerous conditions like endometriosis and inflammation.

Related Experiment Videos

  • Its limited elevation in early-stage disease and lack of effective second-line monitoring hinder its use as a universal screening or monitoring tool.
  • Emerging markers, including lysophosphatidic acid and inhibin, are being investigated for improved diagnostic and prognostic value.

    • Impact:

    • Highlights the limitations of CA125 in ovarian cancer screening and monitoring.
    • Underscores the need for more sensitive and specific tumor markers.
    • Provides insight into the potential of novel biomarkers for improved patient management and outcomes.